FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials

February 5, 2018

Responsive image

SEATTLE, Feb. 5, 2018 /PRNewswire/ — ORICULA THERAPEUTICS, LLC., a biotech company introducing medications to preserve hearing and balance, announced FDA permission to begin volunteer human testing for safety, tolerability, and pharmacokinetics of their novel, new medicine, ORC-13661. In…

Category: Precious Metals